Background: Growing interest in neuroprotection in transcatheter aortic valve replacement (TAVR) has catalyzed the development of cerebral protection systems (CPS).
Objectives: Report insights from consecutive real-world patients undergoing TAVR with the Sentinel-CPS.
Methods: Patients with severe aortic stenosis undergoing TAVR from April 2019 to May 2022 were enrolled in a prospective registry.